- Report
- September 2018
- 111 Pages
Global
From €4439EUR$4,950USD£3,806GBP
- Report
- February 2024
- 338 Pages
Global
From €4439EUR$4,950USD£3,806GBP
- Report
- October 2022
- 320 Pages
Global
From €3363EUR$3,750USD£2,884GBP
- Report
- July 2023
- 114 Pages
Global
From €4170EUR$4,650USD£3,576GBP
- Report
- March 2025
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- August 2025
- 199 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- August 2025
- 198 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- August 2025
- 188 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- July 2025
- 350 Pages
Global
From €4438EUR$4,949USD£3,806GBP
- Report
- July 2025
- 150 Pages
United Kingdom
From €4349EUR$4,850USD£3,729GBP
- Report
- June 2025
- 89 Pages
Europe
From €3542EUR$3,950USD£3,037GBP

Biofabrication is the process of using biological materials to create 3D structures and products. It is a rapidly growing field within the biomaterials industry, as it allows for the production of complex structures with a wide range of applications. Biofabrication is used to create medical implants, tissue engineering scaffolds, and drug delivery systems. It is also used to create food products, such as plant-based meat and dairy alternatives.
Biofabrication is a multi-disciplinary field, combining biology, engineering, and materials science. It involves the use of bioprinting, bioplastics, and other biotechnologies to create products. The process is often automated, allowing for the production of complex structures with high precision.
Biofabrication is a rapidly growing field, with many companies investing in the technology. Some of the leading companies in the market include Modern Meadow, Geltor, and BioBots. Other companies, such as Organovo and Aspect Biosystems, are developing 3D bioprinting technologies for medical applications. Show Less Read more